View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AH43 | Publication ID: Fall 2023 |
Title: Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease | |
Abstract:
This final rule would revoke FDA's regulation authorizing the use of health claims regarding the relationship between soy protein and coronary heart disease on the label or in the labeling of foods. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 101.71 21 CFR 101.82 | |
Legal Authority: 15 U.S.C. 1453 to 1455 21 U.S.C. 321 21 U.S.C. 331 21 U.S.C. 342 to 343 21 U.S.C. 348 21 U.S.C. 371 |
Legal Deadline:
None |
||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Crystal Rivers Nutritionist Department of Health and Human Services Food and Drug Administration 5001 Campus Drive, HFS-830, College Park, MD 20740 Phone:240 402-1450 Email: crystal.rivers@fda.hhs.gov |